Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6729b065750246c23b711a95c72ad775 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2206-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c89549ea27b71c008a807216690ba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f493ee2896716ec0edcb53f7d343ad29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_420a12efcf158b44f1b27cf6ed325059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be0d541196a9608415dde1fc5b549572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f23680272573911a70ae0d0067e04337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa1f9666fb3750dccfde6be1eb5f0aae |
publicationDate |
2020-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020323811-A1 |
titleOfInvention |
Intranasal pharmaceutical composition comprising anticancer drugcontaining nanoparticles for treating brain diseases |
abstract |
The present invention relates to an intranasal pharmaceutical composition comprising anticancer drug-containing nanoparticles for treating brain diseases. More specifically, the anticancer drug-containing nanoparticles are nasally administered to deliver the anticancer drug to only brain cells, thereby increasing therapeutic effects on brain tumor and reducing cytotoxicity to normal cells by an organic solvent used in the conventional delivery of the anticancer drug. |
priorityDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |